No definition available.
Congenital malformations of anterior segment of eye
Q17_CONGEN_MALFO_ANTER_SEGMENT_EYE
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
298 |
4. Check minimum number of eventsNone |
298 |
5. Include endpointsNone |
298 |
6. Filter based on genotype QC (FinnGen only) |
298 |
Control definitions (FinnGen only)
- Control exclude
- Q17_CONGEN_MALFO_EYE_EAR_FACE_NECK
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF4
- Parent code in ICD-10
- Q1
- Name in latin
- Malformationes congenitae segmenti anterioris oculi
Similar endpoints
↥List of similar endpoints to
Congenital malformations of anterior segment of eye
based on the number of shared cases.
Similar with more cases:
- Congenital malformations of eye, ear, face and neck
- Congenital malformations, deformations and chromosomal abnormalities
- Any event in hilmo or specialist outpatient
- Any prescribed medicine buy
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 3928 | 2171 | 1751 |
| Only index persons | 3225 | 1828 | 1397 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.06 | 0.06 | 0.05 |
| Only index persons | 0.06 | 0.07 | 0.05 |
| Median age at first event (years) | |||
| Whole population | 17.73 | 23.82 | 10.13 |
| Only index persons | 25.88 | 30.67 | 19.61 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 298 | 199 | 99 |
| Unadjusted period prevalence (%) | 0.06 | 0.07 | 0.04 |
| Median age at first event (years) | 40.86 | 39.43 | 43.73 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
No data
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 275
- Matched controls
- 2751
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
Q13.2
ICD-10 Finland
Other congenital malformations of iris
+∞
292.7
226
*
Q13.0
ICD-10 Finland
Coloboma of iris
+∞
23.3
22
*
Q13.1
ICD-10 Finland
Absence of iris
+∞
13.7
13
*
H57.0
ICD-10 Finland
Anomalies of pupillary function
42.3
13.3
16
*
Q13.4
ICD-10 Finland
Other congenital corneal malformations
+∞
10.5
10
*
XCK00
NOMESCO Finland
Perimetry
4.3
8.5
31
79
Q14.8
ICD-10 Finland
Other congenital malformations of posterior segment of eye
+∞
8.4
8
*
S01XA20
ATC
artificial tears and other indifferent preparations; ophthalmic
2.2
8.1
113
668
G90.2
ICD-10 Finland
Horner syndrome
46.3
7.8
9
*
Z01.0
ICD-10 Finland
Examination of eyes and vision
2.6
7.7
57
247
XCW99
NOMESCO Finland
Other investigative procedure of eye
3.2
7.6
39
133
S01ED01
ATC
timolol; ophthalmic
7.2
7.4
17
25
XCD00
NOMESCO Finland
Clinical examination of eye in general anaesthesia
71.4
6.5
7
*
ZXA10
NOMESCO Finland
Bilateral
2.4
6.3
57
273
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
151
1120
1.71
4.88
8.2
7.6
mmol/l
1.2
1.2
0.16
122
952
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
12
28
4.42
4.87
1.6
1.4
nmol/l
—
—
—
0
0
(42870588) Differential panel, method unspecified - Blood
117
822
1.70
4.54
7.6
6.4
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
12
31
3.99
4.30
1.6
1.4
—
—
—
0
0
(3036481) Cortisol [Moles/volume] in Serum or Plasma
45
241
2.02
4.17
3.6
2.0
nmol/l
368.0
368.2
0.00
40
225
(3024561) Albumin [Mass/volume] in Serum or Plasma
131
966
1.64
4.13
5.2
4.7
g/l
36.6
36.3
0.21
124
902
(3002030) Lymphocytes/100 leukocytes in Blood
159
1245
1.59
3.82
7.8
6.3
%
30.1
29.2
0.38
154
1170
(3025159) Blasts/100 leukocytes in Blood
35
179
2.08
3.67
6.5
4.8
%
0.0
0.0
0.49
13
50
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
136
1036
1.58
3.62
7.9
7.3
mmol/l
1.2
1.2
0.05
129
951
(3022096) Basophils/100 leukocytes in Blood
149
1162
1.56
3.56
7.8
6.4
%
0.7
0.7
0.12
144
1085
(3019069) Monocytes/100 leukocytes in Blood
154
1211
1.56
3.54
8.1
6.5
%
8.2
8.4
0.39
149
1138
(3006504) Eosinophils/100 leukocytes in Blood
153
1204
1.56
3.49
7.9
6.3
%
3.1
2.8
1.07
148
1123
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
215
1834
1.62
3.40
8.7
7.1
u/l
78.4
80.3
0.26
208
1723
(3021440) Promyelocytes/100 leukocytes in Blood
35
187
1.99
3.27
6.5
4.8
%
0.1
0.1
0.37
14
56
(3002179) Metamyelocytes/100 leukocytes in Blood
34
180
2.00
3.26
6.5
4.4
%
0.6
0.5
0.17
12
39
(3018010) Neutrophils/100 leukocytes in Blood
155
1236
1.53
3.25
7.4
6.1
%
56.2
56.3
0.01
149
1166
(3019198) Lymphocytes [#/volume] in Blood
163
1327
1.50
3.01
7.4
6.2
e9/l
2.2
1.9
1.01
149
1189
(3000494) Fungus identified in Specimen by Culture
46
277
1.78
3.00
1.6
1.5
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
54
345
1.69
2.86
2.1
1.9
—
—
—
0
0
(3001604) Monocytes [#/volume] in Blood
158
1287
1.48
2.86
7.3
6.2
e9/l
0.6
0.6
0.34
140
1122
(3013115) Eosinophils [#/volume] in Blood
162
1329
1.48
2.81
7.4
6.6
e9/l
0.2
0.2
2.14
146
1182
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
9
23
4.00
2.79
1.0
1.2
—
—
—
0
0
(3006315) Basophils [#/volume] in Blood
158
1291
1.48
2.79
7.3
6.2
e9/l
0.0
0.0
0.02
140
1126
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
129
1015
1.48
2.75
2.8
2.3
nmol/l
75.9
75.1
0.12
121
918
(3017181) Myelocytes/100 leukocytes in Blood
35
202
1.83
2.62
6.6
4.5
%
1.6
0.7
0.65
14
65
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
39
233
1.78
2.62
1.9
1.7
—
—
—
0
0
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
104
792
1.48
2.58
2.4
3.5
u/l
26.8
30.2
1.04
94
753
(3015377) Calcium [Moles/volume] in Serum or Plasma
103
784
1.48
2.55
2.9
3.2
mmol/l
2.3
2.4
0.29
90
696
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
39
236
1.75
2.51
2.1
1.8
—
—
—
0
0
(3045683) HLA typing for celiac disease panel - Blood or Tissue
7
16
4.45
2.49
1.1
1.0
—
—
—
0
0
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
95
715
1.48
2.48
3.3
2.3
u/l
56.2
53.6
0.44
90
656
(3048689) Calprotectin [Mass/mass] in Stool
52
342
1.63
2.47
2.3
2.5
ug/g
126.5
122.6
0.02
44
264
(3009508) Creatinine [Moles/volume] in Urine
91
681
1.48
2.44
3.3
2.8
mmol/l
6.9
7.8
1.09
73
575
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
105
809
1.46
2.43
4.1
3.6
ng/l
24.9
33.0
0.57
67
510
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
5
8
6.33
2.38
4.8
7.8
—
—
—
0
0
(3018418) pH of Serum or Plasma
91
686
1.47
2.34
5.4
3.8
ph
7.4
7.4
0.10
24
132
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
12
47
2.62
2.30
4.3
2.5
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
79
583
1.48
2.25
3.1
3.1
mg/l
52.5
45.8
0.10
54
383
(3020682) Albumin/Creatinine [Ratio] in Urine
82
610
1.47
2.25
3.8
3.9
mg/mmol
9.9
8.0
0.14
51
381
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
216
1916
1.46
2.24
5.1
3.9
pmol/l
14.5
14.7
0.36
201
1741
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
62
436
1.53
2.22
1.4
1.7
pmol/l
496.6
449.2
0.56
51
371
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
244
2221
1.54
2.20
13.9
11.3
ml/min/173m2
87.3
87.3
0.01
191
1790
(3032080) INR in Blood by Coagulation assay
107
842
1.42
2.17
11.4
7.9
inr
1.2
1.2
0.07
35
280
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
18
88
2.11
2.16
1.6
1.6
—
—
—
0
0
(3004809) Band form neutrophils/100 leukocytes in Blood
10
37
2.76
2.12
3.7
3.4
%
1.3
1.1
—
10
29
(3007853) Bacteria identified in Skin by Aerobe culture
40
256
1.65
2.12
2.0
1.8
—
—
—
0
0
(3002032) Base excess in Venous blood by calculation
35
218
1.69
2.05
5.0
5.9
mmol/l
1.4
1.8
0.20
29
164
(3012544) pH of Venous blood
36
226
1.67
2.05
5.1
5.9
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
251
2310
1.55
2.03
5.7
4.5
mu/l
1.9
2.4
0.44
231
2120
(3014148) Varicella zoster virus Ab [Titer] in Serum
10
38
2.69
2.03
1.2
1.1
—
—
—
0
0
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
8
26
3.13
2.03
8.5
1.5
pg
33.1
33.2
—
8
26
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
10
39
2.62
1.94
2.9
1.7
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
87
674
1.41
1.90
1.4
1.3
u/ml
0.5
0.9
1.75
24
179
(3038177) Helicobacter pylori Ab [Presence] in Serum
9
34
2.70
1.88
1.3
1.1
—
—
—
0
0
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
27
161
1.74
1.86
8.9
7.1
mmol/l
2.8
1.4
2.15
22
121
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
6
17
3.58
1.84
1.8
2.2
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
12
53
2.32
1.83
4.4
2.7
—
—
—
0
0
(3013650) Neutrophils [#/volume] in Blood by Automated count
171
1484
1.36
1.83
9.8
9.5
e9/l
4.1
4.0
0.27
156
1304
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
13
60
2.22
1.80
1.4
1.5
—
—
—
0
0
(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence
11
47
2.39
1.80
1.1
1.2
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
189
1670
1.36
1.77
5.4
4.1
—
—
—
0
0
(3023323) Follitropin [Units/volume] in Serum or Plasma
25
148
1.75
1.77
1.7
1.5
iu/l
17.0
22.9
0.46
20
123
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
243
2240
1.46
1.76
4.0
3.6
mmol/l
1.3
1.2
0.28
225
2066
(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal
6
18
3.38
1.75
2.0
1.3
—
—
—
0
0
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
75
574
1.41
1.74
2.7
3.6
ng/l
624.7
1009.0
1.61
63
488
(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood
8
30
2.71
1.73
1.1
1.1
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
8
30
2.71
1.73
5.5
2.4
—
—
—
0
0
(3013826) Glucose [Moles/volume] in Serum or Plasma
161
1392
1.34
1.73
4.9
5.1
mmol/l
6.5
6.5
0.12
154
1273
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
267
2512
1.60
1.72
17.6
12.7
mg/l
19.9
21.8
0.44
220
1905
(3028679) Herpes simplex virus Ab [Presence] in Serum
5
13
3.89
1.72
1.2
1.1
—
—
—
0
0
(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma
5
13
3.89
1.72
2.2
3.4
umol/l
23.2
25.2
—
5
13
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
145
1238
1.33
1.68
6.6
6.5
umol/l
11.2
11.4
0.04
140
1159
(40768797) Stomach Pathology biopsy report
45
314
1.51
1.68
1.3
1.2
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
251
2335
1.48
1.66
4.2
4.0
mmol/l
1.5
1.5
0.02
232
2158
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
8
32
2.54
1.61
3.3
1.7
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
16
85
1.93
1.58
2.1
2.2
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
74
577
1.38
1.53
5.7
4.1
—
—
—
0
0
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
5
15
3.37
1.53
1.4
1.3
—
—
—
0
0
(3027945) Reticulocytes/100 erythrocytes in Blood
37
254
1.52
1.50
4.8
3.3
%
1.6
1.8
0.23
32
231
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
251
2349
1.43
1.47
4.4
4.0
mmol/l
4.7
4.7
0.54
233
2185
(3021901) Oxygen saturation in Capillary blood
9
38
2.41
1.47
1.9
3.4
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
7
28
2.54
1.46
1.3
1.3
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
7
29
2.45
1.40
3.9
3.3
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
24
151
1.64
1.40
1.2
1.2
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
6
23
2.64
1.37
2.8
2.4
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
6
23
2.64
1.37
1.0
1.2
—
—
—
0
0
(3011648) Oxygen content in Venous blood
5
17
2.97
1.36
4.0
14.9
%
11.9
12.4
—
5
17
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
9
42
2.18
1.35
1.1
1.0
—
—
—
0
0
(40758558) Short blood count panel - Blood
79
635
1.33
1.34
6.8
7.5
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
85
692
1.32
1.32
4.0
2.7
—
—
—
0
0
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
41
296
1.45
1.31
2.8
2.1
%
22.8
23.3
0.08
34
258
(40761511) CBC panel - Blood by Automated count
273
2608
1.56
1.31
16.3
11.8
—
—
—
0
0
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
81
656
1.32
1.31
2.0
2.2
u/l
181.7
178.6
0.02
76
618
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
5
18
2.81
1.29
4.6
1.4
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
114
970
1.28
1.27
2.1
2.0
—
—
—
0
0
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
274
2623
1.55
1.26
12.2
9.7
u/l
26.7
26.1
0.13
268
2532
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
109
923
1.29
1.26
5.5
3.4
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
55
422
1.37
1.26
1.3
1.3
iu/ml
69.3
27.6
0.58
17
133
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
8
36
2.26
1.25
3.3
1.5
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
133
1156
1.27
1.25
12.2
9.5
e9/l
0.0
0.0
0.82
107
947
(3041096) Erythrocytes [Presence] in Urine by Automated
83
679
1.31
1.24
4.1
3.0
—
—
—
0
0
(3000570) Elastase.pancreatic [Mass/mass] in Stool
12
63
1.94
1.24
1.6
1.4
ug/g
264.4
321.3
—
5
37
(4198724)
5
19
2.66
1.22
1.8
2.1
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
252
2381
1.38
1.20
4.8
4.4
mmol/l
2.8
2.8
0.19
231
2191
(3029937) Albumin [Presence] in Urine by Test strip
80
657
1.30
1.16
6.3
3.7
estimate
0.0
0.0
0.50
34
254
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
16
95
1.72
1.16
1.3
1.7
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
132
1154
1.26
1.16
3.2
2.7
ug/l
100.8
94.2
0.19
121
1060
(3026782) Osmolality of Urine
60
474
1.33
1.15
3.9
2.6
mosm/kgh2o
541.8
549.2
0.09
54
403
(3019060) Gas panel - Arterial blood
20
127
1.62
1.14
6.8
8.6
—
—
—
0
0
(3000850) Epithelial cells [#/volume] in Urine
62
493
1.33
1.13
3.8
2.4
e6/l
10.3
7.6
0.46
54
436
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
7
30
2.36
1.13
3.6
1.6
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
227
2121
1.29
1.10
5.4
5.1
mmol/mol
39.3
39.0
0.22
211
1990
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
12
66
1.85
1.10
2.6
1.7
—
—
—
0
0
(1616796) Gas panel - Central venous blood
8
41
1.98
1.09
11.1
2.5
—
—
—
0
0
(3044889) 12 lead EKG panel
176
1599
1.25
1.07
3.9
3.4
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
23
154
1.53
1.07
1.7
1.6
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
7
34
2.08
1.03
3.6
1.6
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
9
48
1.90
1.01
9.6
4.1
%
52.8
57.4
—
9
48
(3019230) Fractional oxyhemoglobin in Venous blood
7
35
2.02
1.00
3.6
8.1
%
69.7
67.1
—
7
35
(3022313) Gas panel - Capillary blood
20
132
1.55
1.00
11.5
7.9
—
—
—
0
0
(3026493) Urate [Moles/volume] in Serum or Plasma
68
558
1.28
0.99
2.8
2.9
umol/l
326.9
5365.4
2.27
61
481
(3027315) Oxygen [Partial pressure] in Blood
9
49
1.86
0.99
11.1
2.7
kpa
8.9
8.9
—
9
49
(3013290) Carbon dioxide [Partial pressure] in Blood
9
49
1.86
0.99
11.1
2.7
kpa
4.8
5.1
—
9
49
(3013512) EKG study
72
597
1.27
0.97
4.7
3.7
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
9
52
1.75
0.93
3.0
1.7
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
5
102
0.48
0.91
1.6
1.4
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
5
102
0.48
0.91
1.6
1.4
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
8
43
1.88
0.88
3.3
1.5
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
30
222
1.39
0.88
5.9
3.6
—
—
—
0
0
(3015736) pH of Urine
107
941
1.21
0.84
4.5
3.2
—
—
—
0
0
(3037522) Nuclear Ab [Titer] in Serum
43
340
1.31
0.83
1.8
1.4
titre
296.5
464.8
0.94
17
71
(3007164) IgA [Mass/volume] in Serum or Plasma
72
608
1.24
0.83
1.9
1.4
g/l
2.2
2.3
0.14
49
367
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
11
65
1.72
0.83
1.0
1.2
u/ml
0.6
5.1
—
6
31
(44790047)
6
32
1.89
0.82
1.2
1.8
—
—
—
0
0
(44790048)
6
32
1.89
0.82
1.2
1.8
—
—
—
0
0
(44806118)
6
32
1.89
0.82
1.2
1.8
—
—
—
0
0
(44790049)
6
32
1.89
0.82
1.2
1.8
—
—
—
0
0
(3000991) Gas panel - Venous blood
27
199
1.39
0.81
8.0
9.6
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
49
396
1.28
0.81
3.1
3.8
ng/l
463.1
266.0
0.21
29
274
(40768441) Liver Pathology biopsy report
0
24
0.00
0.79
0.0
1.3
—
—
—
0
0
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
0
24
0.00
0.79
0.0
1.5
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
23
166
1.42
0.78
1.0
1.0
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
6
34
1.78
0.76
2.3
4.5
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
64
539
1.24
0.76
5.6
3.4
kg/l
1.0
1.0
—
10
69
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
11
67
1.67
0.76
2.7
1.7
—
—
—
0
0
(3013707) Erythrocyte sedimentation rate by Westergren method
196
1836
1.20
0.75
5.3
4.0
mm/h
8.8
10.6
2.40
188
1677
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
5
24
2.10
0.75
1.0
1.0
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
104
922
1.20
0.74
2.8
2.6
—
—
—
0
0
(3002256) Pathology report gross observation
37
292
1.30
0.74
1.4
1.2
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
6
106
0.56
0.74
1.5
1.5
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
51
420
1.26
0.74
1.3
1.3
u/ml
24.2
8.3
0.47
22
163
(3009466) Valproate [Moles/volume] in Serum or Plasma
7
39
1.81
0.73
4.4
4.8
umol/l
406.9
377.2
—
7
32
(3024928) Oxygen saturation in Venous blood
7
39
1.81
0.73
3.3
8.4
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
10
60
1.69
0.73
1.1
1.3
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
31
239
1.33
0.73
1.5
1.4
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
46
375
1.27
0.72
4.1
4.4
%
24.7
22.0
0.37
20
181
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
9
57
1.60
0.72
1.2
2.2
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
7
40
1.77
0.71
1.6
1.3
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
5
26
1.94
0.71
1.2
1.1
—
—
—
0
0
(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma
9
58
1.57
0.70
1.9
1.7
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
177
1649
1.18
0.70
3.5
3.2
u/l
36.9
41.5
0.68
165
1552
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
27
205
1.35
0.70
1.3
1.3
iu/ml
174.0
156.5
0.11
12
84
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
16
110
1.48
0.70
1.4
1.7
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
131
1192
1.18
0.69
5.0
3.4
estimate
0.0
0.0
0.00
29
254
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
7
42
1.68
0.69
1.0
1.4
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
239
2289
1.22
0.68
4.7
4.1
mmol/l
5.8
5.8
0.16
215
2101
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
14
94
1.51
0.68
1.5
1.3
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
29
224
1.33
0.68
4.5
3.3
—
—
—
0
0
(3000492) Spirometry study
29
224
1.33
0.68
1.6
1.4
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
31
242
1.31
0.67
1.9
1.9
—
—
—
0
0
(4062490)
5
28
1.80
0.66
1.4
1.4
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
131
1196
1.17
0.65
6.3
4.6
estimate
0.0
0.0
0.00
33
256
(3023183) Ammonium ion [Moles/volume] in Plasma
7
44
1.60
0.65
1.9
2.7
umol/l
28.0
36.7
—
7
38
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
54
455
1.23
0.65
2.0
2.1
—
—
—
0
0
(3016293) Bicarbonate [Moles/volume] in Serum or Plasma
23
173
1.36
0.64
11.1
11.2
mmol/l
25.9
25.1
0.52
23
173
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
8
49
1.65
0.62
1.0
1.4
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
37
300
1.27
0.62
2.1
1.8
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
5
30
1.68
0.61
2.0
1.2
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
27
210
1.31
0.61
4.7
4.5
ug/l
2.4
27.4
0.68
22
176
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
55
469
1.21
0.59
5.2
4.8
ug/l
2.0
2.1
0.13
48
413
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
15
106
1.44
0.59
11.9
14.8
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
125
1146
1.16
0.58
4.0
4.1
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
18
133
1.38
0.56
1.4
1.3
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
10
65
1.56
0.56
2.1
2.8
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
8
122
0.65
0.56
1.4
1.4
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
8
122
0.65
0.56
1.4
1.4
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
8
122
0.65
0.56
1.4
1.4
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
8
122
0.65
0.56
1.4
1.4
—
—
—
0
0
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
9
60
1.52
0.55
1.8
1.3
—
2.5
—
0
9
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
9
61
1.49
0.54
1.1
1.3
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
9
62
1.47
0.53
1.9
1.7
—
—
—
0
0
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
9
62
1.47
0.53
1.8
1.3
—
2.5
—
0
13
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
33
271
1.24
0.51
1.8
1.6
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
9
65
1.40
0.51
2.4
1.9
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
43
365
1.21
0.50
1.7
1.5
—
—
—
0
0
(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay
11
76
1.46
0.48
1.2
1.1
—
1.8
—
0
10
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
95
864
1.15
0.48
2.1
1.8
pmol/l
90.8
97.0
0.77
54
436
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
31
373
0.81
0.48
2.9
2.6
e6/l
1.3
0.9
0.41
15
207
(3037121) Protein [Mass/volume] in Urine
12
85
1.43
0.47
7.9
3.2
g/l
0.2
0.2
—
7
39
(3009261) Glucose [Presence] in Urine by Test strip
130
1209
1.13
0.47
5.0
3.4
estimate
0.0
0.0
0.00
33
247
(3019309) Folate [Moles/volume] in Red Blood Cells
45
386
1.20
0.47
1.8
1.6
nmol/l
1084.8
1188.4
0.29
36
287
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
22
274
0.79
0.46
5.7
6.8
—
—
—
0
0
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
11
78
1.43
0.43
2.3
1.9
ug/l
0.6
4.1
0.50
11
70
(3003694) ABO and Rh group [Type] in Blood
69
766
0.87
0.43
1.7
1.5
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
83
754
1.14
0.43
2.4
2.4
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
5
31
1.62
0.43
1.2
1.3
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
6
91
0.65
0.43
1.3
1.2
—
—
—
0
0
(3020891) Body temperature
12
87
1.40
0.43
1.7
5.6
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
12
87
1.40
0.43
1.7
1.4
—
—
—
0
0
(4010399)
20
159
1.28
0.41
1.5
1.4
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
0
16
0.00
0.41
0.0
1.3
—
—
—
0
0
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
0
16
0.00
0.41
0.0
1.2
—
—
—
0
0
(3035947) Staphylolysin Ab [Units/volume] in Serum
0
16
0.00
0.41
0.0
1.1
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
0
16
0.00
0.41
0.0
1.3
—
—
—
0
0
(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma
0
17
0.00
0.41
0.0
1.2
—
189.8
—
0
17
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
0
17
0.00
0.41
0.0
2.9
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
0
17
0.00
0.41
0.0
2.9
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
8
60
1.34
0.40
1.1
1.3
—
—
—
0
0
(3022145) Colonoscopy Study observation
32
270
1.21
0.40
1.3
1.4
—
—
—
0
0
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
0
18
0.00
0.40
0.0
1.5
—
—
—
0
0
(3051014) Leukocytes [#/area] in Urine sediment by Automated count
0
18
0.00
0.40
0.0
1.5
—
0.5
—
0
6
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
14
106
1.34
0.40
1.9
1.9
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
20
160
1.27
0.39
1.2
1.2
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
10
71
1.42
0.39
1.7
1.8
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
15
115
1.32
0.39
2.1
2.0
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
69
623
1.14
0.39
2.0
2.0
—
—
—
0
0
(3044242) Glucose [Moles/volume] in Arterial blood
0
19
0.00
0.39
0.0
4.8
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
24
197
1.24
0.39
1.9
1.8
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
71
643
1.14
0.39
1.5
1.7
mmol/l
1.3
1.3
0.53
59
555
(3019225) pH of Specimen
23
188
1.24
0.39
3.7
4.2
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
12
89
1.36
0.38
1.9
1.6
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
18
143
1.28
0.38
1.5
1.6
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
5
37
1.36
0.37
2.0
1.7
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
12
90
1.35
0.36
1.9
2.0
—
—
—
0
0
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
18
144
1.27
0.36
2.2
2.2
u/l
15563.1
2879.3
—
7
51
(3000764) Benzodiazepines [Presence] in Urine
18
144
1.27
0.36
1.5
1.6
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
18
144
1.27
0.36
1.5
1.6
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
22
265
0.82
0.36
1.4
1.3
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
6
42
1.44
0.35
6.2
4.2
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
6
42
1.44
0.35
2.0
2.0
—
—
—
0
0
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
90
832
1.12
0.35
4.7
3.0
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
6
43
1.40
0.35
1.7
1.6
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
6
43
1.40
0.35
1.7
1.2
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
59
532
1.14
0.35
2.1
2.3
mg/l
0.8
1.2
1.59
48
411
(3028300) Cannabinoids [Presence] in Urine
18
145
1.26
0.34
1.5
1.6
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
6
45
1.34
0.34
1.0
1.4
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
78
718
1.12
0.33
4.2
3.0
e6/l
15.4
44.3
2.06
63
556
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
31
358
0.85
0.33
1.6
1.6
—
—
—
0
0
(3021960) Folate [Moles/volume] in Serum or Plasma
56
507
1.13
0.31
1.6
1.4
nmol/l
21.7
21.0
0.13
51
429
(3044290) Cell count panel - Cerebral spinal fluid
7
53
1.33
0.31
1.6
2.3
—
—
—
0
0
(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
7
53
1.33
0.31
1.9
1.3
—
0.9
—
0
6
(3004119) Hemoglobin [Mass/volume] in Venous blood
16
129
1.25
0.31
4.3
4.9
g/l
131.2
129.8
0.08
16
124
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
10
76
1.33
0.28
1.3
1.6
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
45
405
1.13
0.28
2.0
1.9
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
69
638
1.11
0.27
7.5
4.7
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
10
128
0.77
0.27
1.5
1.5
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
11
86
1.29
0.26
1.8
1.8
—
—
—
0
0
(40761535) Cells panel - Urine sediment
16
190
0.83
0.24
7.6
3.2
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
32
358
0.88
0.24
3.1
2.8
e6/l
1.6
2.6
0.86
15
193
(4035726)
24
209
1.16
0.23
1.5
1.4
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
5
39
1.29
0.23
1.4
1.8
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
5
39
1.29
0.23
1.8
1.7
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
11
88
1.26
0.23
1.2
1.1
—
—
—
0
0
(3003338) MCHC [Mass/volume]
214
2188
0.92
0.22
19.4
16.5
g/l
333.2
332.7
0.41
214
2177
(4306422)
5
40
1.25
0.22
1.2
1.3
—
—
—
0
0
(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose
5
40
1.25
0.22
1.0
1.5
mmol/l
7.0
6.8
—
5
26
(36660697) Celiac disease serology panel - Serum
26
229
1.15
0.22
1.3
1.2
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
11
135
0.81
0.22
1.2
1.7
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
45
412
1.11
0.22
2.7
2.7
mmol/l
2.5
2.4
0.49
37
361
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
5
42
1.19
0.21
1.6
1.2
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
8
102
0.78
0.21
1.4
2.3
—
—
—
0
0
(3020393) Adenovirus Ag [Presence] in Stool
0
11
0.00
0.21
0.0
2.3
—
—
—
0
0
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
0
10
0.00
0.21
0.0
3.4
—
—
—
0
0
(3014271) Vancomycin [Susceptibility]
0
10
0.00
0.21
0.0
2.2
—
—
—
0
0
(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
(3006653) Thiamine [Moles/volume] in Blood
0
10
0.00
0.21
0.0
1.7
—
149.4
—
0
10
(3006922) Hepatitis E virus Ab [Presence] in Serum
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
0
12
0.00
0.21
0.0
1.4
—
—
—
0
0
(3017569) Oxygen content in Arterial blood
0
12
0.00
0.21
0.0
7.1
—
—
—
0
0
(3048402) Erythrocytes [#/area] in Urine sediment by Automated count
0
12
0.00
0.21
0.0
1.3
—
0.9
—
0
7
(3019832) Treponema pallidum Ab [Presence] in Serum
34
375
0.89
0.21
1.7
1.7
—
—
—
0
0
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
0
13
0.00
0.21
0.0
1.8
—
—
—
0
0
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
0
13
0.00
0.21
0.0
1.8
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
0
13
0.00
0.21
0.0
1.8
—
—
—
0
0
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
0
14
0.00
0.20
0.0
1.0
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
35
318
1.11
0.20
2.5
2.1
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
10
122
0.81
0.19
1.5
1.4
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
68
640
1.08
0.19
1.5
1.7
—
—
—
0
0
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
63
591
1.08
0.19
2.4
2.2
mg/l
2.8
3.0
0.48
51
513
(3016879) Cocaine [Presence] in Urine
16
137
1.18
0.19
1.5
1.6
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
7
59
1.19
0.18
1.3
1.2
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
14
119
1.19
0.18
1.6
1.6
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
192
1877
1.06
0.18
3.4
3.5
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
7
63
1.11
0.17
1.4
1.5
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
8
69
1.16
0.16
3.8
2.8
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
50
469
1.08
0.16
1.7
1.4
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
9
79
1.14
0.15
1.1
1.2
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
9
81
1.11
0.15
1.1
1.1
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
11
93
1.19
0.14
1.5
1.8
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
7
89
0.78
0.14
1.3
1.2
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
56
530
1.07
0.14
1.9
1.7
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
89
858
1.05
0.13
4.8
3.6
e6/l
115.1
52.4
0.29
66
587
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
20
219
0.91
0.11
1.5
1.5
—
—
—
0
0
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
17
186
0.91
0.09
2.1
2.3
—
19.4
—
0
5
(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum
6
54
1.11
0.09
5.5
3.4
—
3.4
—
0
7
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
24
224
1.08
0.08
2.8
2.9
g/l
0.2
0.2
0.05
24
210
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
5
61
0.82
0.08
1.0
1.5
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
5
64
0.78
0.08
3.8
3.8
—
—
—
0
0
(3020044) Glucose [Moles/volume] in Cerebral spinal fluid
7
65
1.08
0.08
1.0
2.0
mmol/l
4.2
3.7
—
7
58
(3011397) Hemoglobin [Presence] in Urine by Test strip
53
550
0.96
0.08
5.7
3.4
—
—
—
0
0
(3043409) Potassium [Moles/volume] in Arterial blood
6
71
0.84
0.07
1.5
4.4
mmol/l
3.4
3.9
—
6
62
(3003396) Base excess in Arterial blood by calculation
25
235
1.07
0.07
8.8
10.1
mmol/l
2.0
1.1
0.71
17
186
(3030467) Casts [#/volume] in Urine by Automated count
67
650
1.04
0.07
4.2
2.9
e6/l
0.2
0.4
0.68
51
491
(1002224) Polysomnography panel
10
112
0.89
0.07
1.0
1.1
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
21
196
1.08
0.07
1.8
1.4
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
7
81
0.86
0.07
1.3
1.4
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
9
84
1.07
0.07
1.1
1.2
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
12
131
0.91
0.05
3.4
2.3
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
233
2346
0.97
0.05
17.1
13.7
%
39.8
40.1
0.30
178
1804
(40768443) Skin Pathology biopsy report
11
101
1.09
0.04
1.5
1.1
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
14
149
0.94
0.03
1.1
1.6
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
28
270
1.04
0.03
2.6
2.9
ug/l
0.7
0.8
0.15
17
180
(3045414) Leukocytes [Presence] in Urine
11
102
1.08
0.03
1.6
1.7
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
57
580
0.98
0.02
2.6
2.4
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
10
93
1.08
0.02
2.4
2.0
—
—
—
0
0
(3008898) HLA-B27 [Presence]
12
127
0.94
0.01
1.4
1.1
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
11
104
1.06
0.01
1.5
1.4
—
—
—
0
0
(3036489) Thrombin time
11
108
1.02
0.00
1.1
4.7
s
23.2
22.3
—
5
96
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
26
258
1.01
0.00
4.3
4.2
%
30.0
31.6
0.43
21
168
(3004716) Salmonella sp identified in Stool by Organism specific culture
15
151
0.99
0.00
1.3
1.2
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
11
105
1.05
0.00
2.7
3.1
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
19
185
1.03
0.00
6.2
2.9
ml/min/173m2
65.7
68.7
0.16
12
72
(36304419) Bacteria [Presence] in Urine
64
645
0.99
0.00
4.4
2.8
—
—
—
0
0
(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma
5
51
0.98
0.00
2.8
1.3
ug/l
1.8
2.8
—
5
45
(3032567) Hepatitis B virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
0
8
0.00
0.00
0.0
2.3
—
—
—
0
0
(3002619) Bacteria identified in Specimen by Culture
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3035880) pH of Pleural fluid
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
8
0.00
0.00
0.0
1.4
—
—
—
0
0
(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3032057) Clostridioides difficile [Presence] in Stool
0
5
0.00
0.00
0.0
2.2
—
—
—
0
0
(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay
0
5
0.00
0.00
0.0
1.0
—
24.0
—
0
5
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
0
9
0.00
0.00
0.0
1.1
—
7.9
—
0
9
(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting
5
56
0.89
0.00
1.0
1.3
nmol/l
0.7
0.8
—
5
48
(3008536) Aspergillus sp Ab [Presence] in Serum
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(3034988) Calcium [Moles/volume] in Capillary blood
0
6
0.00
0.00
0.0
2.7
—
1.2
—
0
6
(40768793) Breast Pathology biopsy report
6
64
0.94
0.00
1.7
1.3
—
—
—
0
0
(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3039602) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Capillary blood
0
6
0.00
0.00
0.0
2.5
—
1.3
—
0
6
(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(4133840)
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3033888) Pepsinogen I [Mass/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.2
—
70.6
—
0
6
(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
5
53
0.94
0.00
1.6
1.2
—
—
—
0
0
(3001964) Herpes simplex virus Ag [Presence] in Specimen
0
9
0.00
0.00
0.0
2.1
—
—
—
0
0
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
5
53
0.94
0.00
1.4
1.3
—
—
—
0
0
(3034426) Prothrombin time (PT)
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(3004446) Plasmodium sp identified in Blood by Light microscopy
0
7
0.00
0.00
0.0
3.0
—
—
—
0
0
(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(4034850)
7
76
0.92
0.00
8.7
10.1
—
—
—
0
0
(3022621) pH of Urine by Test strip
14
140
1.00
0.00
3.6
2.2
—
—
—
0
0
(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
2.6
—
—
—
0
0
(40758292) HTLV I+II Ab panel - Serum
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(3032352) Blasts [#/volume] in Cerebral spinal fluid
0
6
0.00
0.00
0.0
7.3
—
—
—
0
0
(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3027901) Hemoglobin [Mass/volume] in Arterial cord blood
0
5
0.00
0.00
0.0
1.0
—
157.2
—
0
5
(44806420)
0
6
0.00
0.00
0.0
2.5
—
—
—
0
0
(3015479) Mycobacterium sp identified in Blood by Organism specific culture
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3017115) Methotrexate [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
13.8
—
0.4
—
0
6
(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
5
53
0.94
0.00
1.6
1.2
—
—
—
0
0
(3019473) Protein [Mass/volume] in Cerebral spinal fluid
7
71
0.99
0.00
1.1
2.0
mg/l
429.0
420.4
—
7
66
Mortality – FinRegistry
↥Association
Association between endpoint Q17_CONGEN_MALFO_ANTER_SEGMENT_EYE and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| Q17_CONGEN_MALFO_ANTER_SEGMENT_EYE | 1.16 [0.95, 1.41] | 0.138 |
| Birth year | 0.997 [0.99, 1.01] | 0.48 |
During the follow-up period (1.1.1998 — 31.12.2019), 111 out of 2105 females with Q17_CONGEN_MALFO_ANTER_SEGMENT_EYE died.
Males
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| Q17_CONGEN_MALFO_ANTER_SEGMENT_EYE | 1.031 [0.81, 1.31] | 0.799 |
| Birth year | 0.984 [0.97, 0.99] | 0.002 |
During the follow-up period (1.1.1998 — 31.12.2019), 104 out of 1688 males with Q17_CONGEN_MALFO_ANTER_SEGMENT_EYE died.
Mortality risk
Mortality risk for people of age
years, who have Q17_CONGEN_MALFO_ANTER_SEGMENT_EYE.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.12% | 0.199% |
| 5 | 0.737% | 1.156% |
| 10 | 1.857% | 2.918% |
| 15 | 3.662% | 5.273% |
| 20 | 6.114% | 8.716% |
Relationships between endpoints
↥Index endpoint: Q17_CONGEN_MALFO_ANTER_SEGMENT_EYE – Congenital malformations of anterior segment of eye
GWS hits: 1
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data